Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bhatt

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
American Journal of Preventive Medicine|April 30, 2023
Economics of Team-Based Care for Blood Pressure Control: Updated Community Guide Systematic ReviewVerughese Jacob, Jeffrey A Reynolds, Sajal K Chattopadhyay, et al.
Bioorganic & Medicinal Chemistry|March 10, 2026
Novel antiviral compounds: Synthesis, biological studies on SARS-CoV-2, and structure-activity relationship analysisSumit Kumar, Renata Pessôa Germano Mendes, Meenakshi Bansal, et al.
Current Topics in Medicinal Chemistry|December 6, 2014
Modifications of cell signalling and redox balance by targeting protein acetylation using natural and engineered molecules: implications in cancer therapyKavya Venkateswaran, Amit Verma, Anant N Bhatt, et al.
International Journal of Clinical Practice|August 22, 2015
Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignanciesS Faithfull, A Lemanska, P Aslet, et al.
Annals of the New York Academy of Sciences|March 4, 1977
Recent studies on the antiviral and biochemical properties of 5-halo-5'-amino-deoxyribonucleosidesW H Prusoff, D C Ward, T S Lin, et al.
Archives of Pathology & Laboratory Medicine|November 24, 2025
Laboratory Workup of AmyloidosisDylan V Miller, Kunal N Bhatt, Gregary T Bocsi, et al.
Biotechnology Progress|April 3, 2024
Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregatesNikki McArthur, Bokyung Kang, Felix G Rivera Moctezuma, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study designAndrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settingsW Sabiiti, B Mtafya, D Kuchaka, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
American Journal of Preventive Medicine|April 30, 2023
Economics of Team-Based Care for Blood Pressure Control: Updated Community Guide Systematic ReviewVerughese Jacob, Jeffrey A Reynolds, Sajal K Chattopadhyay, et al.
Bioorganic & Medicinal Chemistry|March 10, 2026
Novel antiviral compounds: Synthesis, biological studies on SARS-CoV-2, and structure-activity relationship analysisSumit Kumar, Renata Pessôa Germano Mendes, Meenakshi Bansal, et al.
Current Topics in Medicinal Chemistry|December 6, 2014
Modifications of cell signalling and redox balance by targeting protein acetylation using natural and engineered molecules: implications in cancer therapyKavya Venkateswaran, Amit Verma, Anant N Bhatt, et al.
International Journal of Clinical Practice|August 22, 2015
Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignanciesS Faithfull, A Lemanska, P Aslet, et al.
Annals of the New York Academy of Sciences|March 4, 1977
Recent studies on the antiviral and biochemical properties of 5-halo-5'-amino-deoxyribonucleosidesW H Prusoff, D C Ward, T S Lin, et al.
Archives of Pathology & Laboratory Medicine|November 24, 2025
Laboratory Workup of AmyloidosisDylan V Miller, Kunal N Bhatt, Gregary T Bocsi, et al.
Biotechnology Progress|April 3, 2024
Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregatesNikki McArthur, Bokyung Kang, Felix G Rivera Moctezuma, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study designAndrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settingsW Sabiiti, B Mtafya, D Kuchaka, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.
Pageof 21